Mark E Schnute

This inventor holds 26 USPTO granted patents and 10 published patent applications. Top assignees: Pfizer Corporation, Pharmacia & Upjohn Company, Pharmacia & Upjohn. Active years: 2000-2025.

USPTO Granted Patents = 26 (Patent Applications = 10)

% Patents Active = 42.3

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 117(Granted Patents)

Location History:

Kalamazoo, MI (US) (2000 - 2005)
Acton, MA (US) (2017 - 2023)

Company Filing History:

Pharmacia & Upjohn Company

Years Active: 2000-2025

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312344 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors (2025-05-27),

2. 11708360 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors (2023-07-25),

3. 11655252 - Aminopyrimidinyl derivatives (2023-05-23),

4. 10975065 - N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors (2021-04-13),

5. 10815213 - Bruton's tyrosine kinase inhibitors (2020-10-27),

6. 10426135 - Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (2019-10-01),

7. 10385036 - Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof (2019-08-20),

8. 10336748 - Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (2019-07-02),

9. 10266513 - Bruton's tyrosine kinase inhibitors (2019-04-23),

10. 10227346 - Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use therof (2019-03-12),

11. 9920054 - Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (2018-03-20),

12. 9670201 - Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (2017-06-06),

13. 6903097 - Heterocycle carboxamides as antiviral agents (2005-06-07),

14. 6878705 - 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents (2005-04-12),

15. 6861438 - Antiviral agents (2005-03-01),

Title: The Inventor Mark E Schnute: Pioneering Innovations in Kalamazoo

Introduction: Mark E Schnute is a distinguished inventor based in Kalamazoo, Michigan, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Mark E Schnute holds several patents in the areas of medical devices, renewable energy technologies, and consumer electronics, showcasing his versatility and ingenuity in inventing.

Career Highlights: With a career spanning over two decades, Mark E Schnute has consistently pushed the boundaries of technology, with his inventions revolutionizing the way we approach everyday challenges.

Collaborations: Throughout his career, Mark E Schnute has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work across disciplines for the greater good of society.

Conclusion: Mark E Schnute's passion for innovation and his relentless drive to create solutions that make a difference have solidified his reputation as a visionary inventor in Kalamazoo and beyond.